Login

SOSVs program for startups with a hardware element|Cyril Ebersweiler,General Partner,HAX 00:10:00

Share On Facebook Share On Twitter

General Partner at SOSV and the founder/MD of HAX.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Driving the Electric Vehicle Revolution: Ethical Copper and Cobalt Mining in the DRC
00:10:00
Stephen Hemsley Reflects on a Successful 2022 and Outlines Expectations for 2023 | Stephen Hemsley, CEO , Franchise Brands PLC.
00:10:00
The CEO Outlook highlights that dotdigital Group Plc, a UK-based company, provides software as a service (SaaS) solutions, focusing on omnichannel marketing automation and customer engagement platforms​ |Milan Patel, CEO of Dotdigital
00:10:00
Exclusive Interview: Richard Youle, Co-Head of Private Equity at Skadden Arps, Shares Insights | John Slate - Founder of Skadden
00:10:00
Unlocking Creativity: The Gamma Revolution - A Journey of Problem-Solving and Innovation|Grant Lee,CEO,Gamma
00:10:00
Mission is to build great businesses and deliver strong returns to investors|Wong Teek Son,Executive Chairman,Riverstone Holdings
00:10:00
Tom Williams on Downing Renewables & Infrastructure Trust: Q1 Performance and Swedish Market Developments | Tom William, Manager, Downing Renewables and Infrastructure Trust PLC.
00:10:00
Jesse Fink: A Journey of Impact and Philanthropy in Action at MissionPoint Capital Partners
00:10:00
Q2 Market Update: Cautious Optimism Amid Global Uncertainty
00:10:00
In Discussion with Apax Partners CEO Eddie Misrahi | Eddie Misrahi, CEO, APAX Partners.
00:10:00
Medusa Mining: Unveiling Value and Growth Potential
00:10:00
Market Pulse: Navigating Interest Rate Uncertainty with Bell Direct’s Morning Bell | Sydney Market Insights

© 2017 - Neuhu+